Skip to main content
Cognitive Revolution

AMA Part 1: Is Claude Code AGI? Are we in a bubble? Plus Live Player Analysis

114 min episode · 2 min read

Episode

114 min

Read time

2 min

Topics

Investing, Startups, Fundraising & VC

AI-Generated Summary

Key Takeaways

  • Medical AI Application: Using top-tier models (GPT-5.2 Pro, Claude Opus 4.5, Gemini 3) with maximum context and multiple opinions provides oncologist-level analysis for cancer cases. Minimal residual disease testing reduced detectable cancer cells from one in ten to fewer than one in million, demonstrating both treatment success and AI-assisted decision making effectiveness.
  • Claude Code Performance: Claude Opus 4.5 excels at software development tasks, enabling creation of three functional apps in approximately three workdays each. The model handles full-stack development from planning through deployment, though occasional database conflicts require exporting entire codebases to fresh model instances for comprehensive debugging beyond agentic search capabilities.
  • Chinese AI Model Gap: Testing DeepSeek, Kimi, Qwen, and GLM models on document reading tasks reveals significant performance gaps compared to US frontier models. Chinese models return only 20% accurate information on complex vision tasks while Gemini 3 and Claude Opus 4.5 achieve near-perfect accuracy, suggesting chip controls limit inference scaling and customer feedback loops essential for model refinement.
  • AI Investment Bubble Indicators: LM Arena raising $100-150 million at $1.7 billion valuation based on $30 million annualized consumption run rate (free usage value, not revenue) exemplifies venture overvaluation. Similar patterns across AI startups suggest many investments will fail despite transformative technology potential, analogous to railroad bubble where infrastructure proved valuable but individual companies defaulted.
  • Live Player Rankings: Google DeepMind leads with TPU infrastructure, billion-dollar weekly profits, deepest research bench, and distribution to billions of users. OpenAI pursues too-big-to-fail strategy through aggressive debt and balance sheet commingling. Anthropic demonstrates best safety work and model performance but maintains concerning stance on recursive self-improvement inevitability and China containment strategy.

What It Covers

Nathan Labenz shares personal updates on his son's cancer treatment, evaluates Claude Opus 4.5's capabilities and holiday hype, analyzes potential AI investment bubbles, and provides detailed assessments of major AI companies including Google DeepMind, OpenAI, Anthropic, and XAI.

Key Questions Answered

  • Medical AI Application: Using top-tier models (GPT-5.2 Pro, Claude Opus 4.5, Gemini 3) with maximum context and multiple opinions provides oncologist-level analysis for cancer cases. Minimal residual disease testing reduced detectable cancer cells from one in ten to fewer than one in million, demonstrating both treatment success and AI-assisted decision making effectiveness.
  • Claude Code Performance: Claude Opus 4.5 excels at software development tasks, enabling creation of three functional apps in approximately three workdays each. The model handles full-stack development from planning through deployment, though occasional database conflicts require exporting entire codebases to fresh model instances for comprehensive debugging beyond agentic search capabilities.
  • Chinese AI Model Gap: Testing DeepSeek, Kimi, Qwen, and GLM models on document reading tasks reveals significant performance gaps compared to US frontier models. Chinese models return only 20% accurate information on complex vision tasks while Gemini 3 and Claude Opus 4.5 achieve near-perfect accuracy, suggesting chip controls limit inference scaling and customer feedback loops essential for model refinement.
  • AI Investment Bubble Indicators: LM Arena raising $100-150 million at $1.7 billion valuation based on $30 million annualized consumption run rate (free usage value, not revenue) exemplifies venture overvaluation. Similar patterns across AI startups suggest many investments will fail despite transformative technology potential, analogous to railroad bubble where infrastructure proved valuable but individual companies defaulted.
  • Live Player Rankings: Google DeepMind leads with TPU infrastructure, billion-dollar weekly profits, deepest research bench, and distribution to billions of users. OpenAI pursues too-big-to-fail strategy through aggressive debt and balance sheet commingling. Anthropic demonstrates best safety work and model performance but maintains concerning stance on recursive self-improvement inevitability and China containment strategy.

Notable Moment

Nathan discovers that exporting entire codebases to fresh Claude instances solves debugging problems that agentic search misses. When Cloud Code created duplicate databases through misinterpreted instructions, only viewing the full context simultaneously revealed which database was actually active, demonstrating current limitations in agentic workflows versus comprehensive context analysis.

Know someone who'd find this useful?

Episode Transcript

Welcome back to the cognitive revolution. This is our AMA episode. My schedule has been a little bit crazy lately, and so I never actually really scheduled this with anyone. And so there's nobody here to ask me the question, so I'm just gonna read the questions myself and then give you my answers. But I did get some really good questions, and I'm excited to answer them. And hopefully, people will enjoy this episode and, find some value in it. With that, by far the first and most important question and and the most common question that I'm getting these days is how is my son Ernie, doing since the big episode that I did about his cancer back in November. And the good news is he is doing really quite well. I'm very pleased to report that. Certainly, cancer, and certainly cancer of this type being as aggressive as it is, and I won't belabor the whole thing from last time. Go check out the two hour monologue on that if you want the full story. But a cancer this aggressive, which can double as quickly as every twenty four hours, does get very aggressive treatment. And so he has been through the wringer with the chemotherapy. He's through basically half the chemotherapy now. There are six rounds in total, and he's been through three. The final two rounds, the rounds five and six are supposed to be a little more mild than the first four. So depending on how you count, we could say he's maybe a little more than halfway through the treatment, but somewhere that and, it's definitely been rough on him. There's no doubt about it. When he went into the hospital, he was fifty one pounds. He's still forty one pounds today, and that's that's what the weight that he came home at after the first round of treatment. He's been able to gain a little weight, lost it back, gained a little, gets dehydrated, loses a little. So you can just see looking at him, he's super thin. He's quite pale. He's definitely not nearly as strong as he was before we went in. But on the markers that really count the most, namely, like, does it look like the cancer is being effectively treated? There, he looks really good. After the first round of chemotherapy, the PET scan that he had showed no obvious focal points of cancer. And when our oncologist met with the tumor board, they all agreed that it made sense to classify him as being in remission as of before he even started the second round of treatment. So that is great. We also, if you listen to that earlier long episode, might recall that one of the things that AI helped me do is identify some additional testing that is not yet standard of care, but can be done to try to get a better, more sensitive take on, is there any cancer left in his …

Get the full transcript (21,701 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Cognitive Revolution transcripts →

You just read a 3-minute summary of a 111-minute episode.

Get Cognitive Revolution summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

Books, tools, and gear mentioned in this episode

SignalCast may earn commission on purchases via these links.

Tools

  • by MongoDB

    💼 SPONSORS [MongoDB, Framer, Tasklet]
  • Testing DeepSeek, Kimi, Qwen, and GLM models on document reading tasks reveals significant performance gaps compared to US frontier models.
  • Testing DeepSeek, Kimi, Qwen, and GLM models on document reading tasks reveals significant performance gaps compared to US frontier models.
  • by Framer

    💼 SPONSORS [MongoDB, Framer, Tasklet]
  • Claude Opus 4.5Recommended

    by Anthropic

    Claude Opus 4.5's capabilities and holiday hype... Claude Opus 4.5 excels at software development tasks, enabling creation of three functional apps in approximately three workdays each.
  • Testing DeepSeek, Kimi, Qwen, and GLM models on document reading tasks reveals significant performance gaps compared to US frontier models.
  • by Tasklet

    💼 SPONSORS [MongoDB, Framer, Tasklet]
  • by OpenAI

    Using top-tier models (GPT-5.2 Pro, Claude Opus 4.5, Gemini 3) with maximum context and multiple opinions provides oncologist-level analysis for cancer cases.

More from Cognitive Revolution

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best AI Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Cognitive Revolution.

Every Monday, we deliver AI summaries of the latest episodes from Cognitive Revolution and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime